Suma Krishnan is President, R&D of Krystal Biotech, Inc.. Currently has a direct ownership of 1.46 Million shares of KRYS, which is worth approximately $274 Million. The most recent transaction as insider was on Feb 26, 2021, when has been sold 28,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.46M
0.82% 3M change
5.62% 12M change
Total Value Held $274 Million

Suma Krishnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 26 2021
BUY
Grant, award, or other acquisition
-
28,400 Added 1.5%
1,864,464 Common Stock
SK

Suma Krishnan

President, R&D
Pittsburgh, PA

Track Institutional and Insider Activities on KRYS

Follow Krystal Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

News

Receive news related to Krystal Biotech, Inc.

Track Activities on KRYS